iLive Connect has officially launched in India, bringing a doctor-led continuous care model directly into patients’ homes. The platform combines medical expertise with technology to monitor health on an ongoing basis and enable timely medical action when needed.
India’s healthcare system is under increasing pressure due to an ageing population, a rise in chronic illnesses, frequent cardiac emergencies, avoidable hospital admissions, and the lack of regular medical supervision outside hospitals. iLive Connect aims to bridge this gap by ensuring patients remain under medical watch even when they are not admitted to a healthcare facility.
The platform operates as a 24×7 continuous care service that tracks health data in real time and supports early medical intervention, often before symptoms become noticeable. It uses medical-grade, FDA- and CE-certified wearable biosensors to monitor key vital signs. These are linked to a digital platform that analyses health trends, supported by AI-based risk assessment to flag early warning signs. A dedicated medical command centre, staffed round the clock by specialist doctors, actively monitors patient data, responds to alerts, and ensures access to doctors along with a dedicated iLive Expert.
Dr Rahul Chandola, leading cardiovascular and aortic surgeon and Founder of iLive Connect, said, “Healthcare does not start or end within hospital walls. Most health changes happen in everyday life, outside clinical settings. iLive was created to monitor these everyday moments through continuous tracking, medical oversight, and early intervention, so health issues can be addressed before they escalate. This approach represents the future of healthcare, in India and globally.”
Dr Viveka Kumar, leading interventional cardiologist and Co-founder of iLive Connect, added, “iLive Connect is India’s first fully integrated continuous care platform managed around the clock by super-specialist doctors. Our goal is to provide a reliable safety net that blends advanced technology with experienced medical care, offering timely support and reassurance to patients and their families in India and overseas.”
iLive Connect moves healthcare away from a reactive model and towards prevention by providing round-the-clock access to doctors and continuous medical oversight. By monitoring health data in real time, the platform can identify early warning signs and potential risks well before symptoms appear, allowing timely medical guidance and intervention.
This proactive approach helps reduce avoidable emergencies and hospital admissions while improving outcomes for people with chronic or high-risk conditions. Continuous, doctor-led monitoring also offers families peace of mind, knowing that their loved ones are under constant medical supervision even when they are at home. iLive is designed to complement doctors and hospitals, not replace them. By enabling timely, personalised care, it strengthens the healthcare system and supports patients beyond traditional hospital settings.
For individuals living with conditions such as diabetes, high blood pressure, COPD, asthma, or heart failure, continuous monitoring helps manage disease more effectively and reduces the risk of sudden complications. The platform is also suited for elderly individuals and those under remote care, offering caregivers regular updates and dependable medical supervision.
IHLD Med Tech Pvt Ltd is a medtech company headquartered in Gurugram, India. It operates in the healthcare and health services sector and is associated with the Institute of Heart and Lungs Diseases (IHLD) Research Centre. IHLD was founded by Dr Rahul Chandola, a senior clinician with extensive experience in cardiothoracic and vascular care, providing strong clinical leadership to the company’s healthcare initiatives.
